These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 12231372)
1. The use of (99m)technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts. Kown MH; Jahncke CL; Lijkwan MA; Koransky ML; Mari C; Berry GJ; Blankenberg FG; Strauss HW; Robbins RC J Heart Lung Transplant; 2002 Sep; 21(9):1009-15. PubMed ID: 12231372 [TBL] [Abstract][Full Text] [Related]
2. Prolonged cold ischemia in rat cardiac allografts promotes ischemia-reperfusion injury and the development of graft coronary artery disease in a linear fashion. Tanaka M; Mokhtari GK; Terry RD; Gunawan F; Balsam LB; Hoyt G; Lee KH; Tsao PS; Robbins RC J Heart Lung Transplant; 2005 Nov; 24(11):1906-14. PubMed ID: 16297799 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts. Lijkwan MA; Cooke DT; Martens JM; Kown MH; Murata S; Peterson SH; Hoyt EG; Robbins RC J Heart Lung Transplant; 2005 Apr; 24(4):439-45. PubMed ID: 15797746 [TBL] [Abstract][Full Text] [Related]
4. Bcl-2-mediated inhibition of apoptosis in rat cardiac allografts worsens development of graft coronary artery disease. Kown MH; Miniati DN; Jahncke CL; Lijkwan MA; Murata S; Koransky ML; Blankenberg FG; Strauss HW; Robbins RC J Heart Lung Transplant; 2003 Sep; 22(9):986-92. PubMed ID: 12957608 [TBL] [Abstract][Full Text] [Related]
5. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model. Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747 [TBL] [Abstract][Full Text] [Related]
6. The use of technetium Tc 99m annexin V for in vivo imaging of apoptosis during cardiac allograft rejection. Vriens PW; Blankenberg FG; Stoot JH; Ohtsuki K; Berry GJ; Tait JF; Strauss HW; Robbins RC J Thorac Cardiovasc Surg; 1998 Nov; 116(5):844-53. PubMed ID: 9806391 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of graft coronary arteriosclerosis after heart transplantation. Soukiasian HJ; Czer LS; Wang HM; Luthringer D; Wang C; Kamlot A; Quartel A; Trento A Am Surg; 2004 Oct; 70(10):833-40. PubMed ID: 15529833 [TBL] [Abstract][Full Text] [Related]
8. Effects of adenoviral up-regulation of bcl-2 on oxidative stress and graft coronary artery disease in rat heart transplants. Miniati DN; Lijkwan MA; Murata S; Martens J; Coleman CT; Hoyt EG; Robbins RC Transplantation; 2003 Jul; 76(2):382-6. PubMed ID: 12883197 [TBL] [Abstract][Full Text] [Related]
16. Effects of Monocyte Chemotactic Protein-1 and Nuclear Factor of Kappa B Pathway in Rejection of Cardiac Allograft in Rat. Bai X; Qi Z; Song G; Zhao X; Zhao H; Meng X; Liu C; Bing W; Bi Y Transplant Proc; 2015; 47(6):2010-6. PubMed ID: 26293090 [TBL] [Abstract][Full Text] [Related]
17. Zinc chloride-mediated reduction of apoptosis as an adjunct immunosuppressive modality in cardiac transplantation. Kown MH; van der Steenhoven TJ; Jahncke CL; Mari C; Lijkwan MA; Koransky ML; Blankenberg FG; Strauss HW; Robbins RC J Heart Lung Transplant; 2002 Mar; 21(3):360-5. PubMed ID: 11897525 [TBL] [Abstract][Full Text] [Related]
18. Use of [18F]FDG Positron Emission Tomography to Monitor the Development of Cardiac Allograft Rejection. Daly KP; Dearling JL; Seto T; Dunning P; Fahey F; Packard AB; Briscoe DM Transplantation; 2015 Sep; 99(9):e132-9. PubMed ID: 25675207 [TBL] [Abstract][Full Text] [Related]
19. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Russell ME; Adams DH; Wyner LR; Yamashita Y; Halnon NJ; Karnovsky MJ Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6086-90. PubMed ID: 8327487 [TBL] [Abstract][Full Text] [Related]